Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Resilience19on Feb 22, 2021 8:54am
121 Views
Post# 32624629

RE:RE:4000 -10000 -12000 tests per week

RE:RE:4000 -10000 -12000 tests per week@Mary, I read you on erring on the side of caution and factoring in an average of 8,000 tests per week. However, that we were already at 12,000 tests per week by the end of the first week of February, I'm working on DM having already been processing 10,000/wk 01 Jan, project 14,000/wk by 01 Mar and 16,000/wk by 01 Apr - roughly giving an average of 13,000/wk throughout Q1 or $32,5M for Q1, which I round diwn to $30M. I think this volume is further substantiated by the variants, which have increasingly been worrying, since early Jan and likely led to higher testing volumes. Granted, it's a more agressive planning figure but am confident it's reasonable in the current context. This said, it's simply a number I use but appreciate and respect others having more conservative or ambitious targets..cheers and GLTA.
maryhill wrote: Napkin Math using the 4000 test estimate

  4000 tests = $20,000,000 divided by 28 weeks =    $715,000 dollars per week
  8000 tests = $40,000,000 divided by 28 weeks = $1,430.000 dollars per week
12000 tests = $60.000.000 divided by 28 weeks = $ 2,860,000 dollars per week

If on average, 8000 tests per week  in Q1, Revenue could be $17 million consevatively

I know, in Marshalls webinar he mentioned 12,000 tests but lets be conservative based on known facts and projections from October news release.

maryhill wrote: That revevenue adds up fast eh !

Newsfile Corp.
management believes that the Company is on track to achieve approximately 4,000 tests per week, based on current operations Datametrex, current cost and revenue model, would result in revenue of approximately $20 million over the next 28 weeks. 
Marshal Gunter, CEO, said, "I must first say thank you to the entire team at Datametrex along with the medical and lab professionals for their tireless work at the company. We are ramping up our business to meet increasing demand and our expectation based on what we are seeing in the market is to execute on approximately 10,000 tests per week on a progressive basis. We are witnessing a paradigm shift within the film industry...... The demand remains high for qualified medical professionals from the private sector to be on site, and in the lab, ensuring complete and timely delivery of coronavirus tests supplied by Datametrex." He continued, "with our growing revenue model, we remain committed to our shareholders and will announce further developments with additional conference calls and press releases in the coming weeks."

https://ca.finance.yahoo.com/news/datametrex-expands-distribution-film-televison-143200075.html




<< Previous
Bullboard Posts
Next >>